Clinical trial
Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?
NCT02520518 is registered in ClinicalTrials.gov with Christopher Bell as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?
- Lead sponsor
- Christopher Bell
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 31, 2015
- Completion date
- May 31, 2017
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.